175 related articles for article (PubMed ID: 32311194)
21. Outcome of breast cancer screening in Denmark.
Lynge E; Bak M; von Euler-Chelpin M; Kroman N; Lernevall A; Mogensen NB; Schwartz W; Wronecki AJ; Vejborg I
BMC Cancer; 2017 Dec; 17(1):897. PubMed ID: 29282034
[TBL] [Abstract][Full Text] [Related]
22. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer in Singapore: some perspectives.
Jara-Lazaro AR; Thilagaratnam S; Tan PH
Breast Cancer; 2010; 17(1):23-8. PubMed ID: 19701678
[TBL] [Abstract][Full Text] [Related]
24. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
[TBL] [Abstract][Full Text] [Related]
25. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
Aragon R; Morgan J; Wong JH; Lum S
Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer survival among women under age 50: is mammography detrimental?
Stacey-Clear A; McCarthy KA; Hall DA; Pile-Spellman E; White G; Hulka C; Whitman GJ; Mahoney E; Kopans DB
Lancet; 1992 Oct; 340(8826):991-4. PubMed ID: 1357448
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
28. Cumulative risk of cancer detection in breast cancer screening by protocol strategy.
Blanch J; Sala M; Román M; Ederra M; Salas D; Zubizarreta R; Sanchez M; Rué M; Castells X;
Breast Cancer Res Treat; 2013 Apr; 138(3):869-77. PubMed ID: 23471648
[TBL] [Abstract][Full Text] [Related]
29. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
31. Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.
Ponti A; Ronco G; Lynge E; Tomatis M; Anttila A; Ascunce N; Broeders M; Bulliard JL; Castellano I; Fitzpatrick P; Frigerio A; Hofvind S; Májek O; Segnan N; Taplin S;
Breast Cancer Res Treat; 2019 Oct; 177(3):761-765. PubMed ID: 31250357
[TBL] [Abstract][Full Text] [Related]
32. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
[TBL] [Abstract][Full Text] [Related]
33. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
34. Impact of hormone replacement therapy use on mammographic screening outcomes.
Beckmann KR; Farshid G; Roder DM; Hiller JE; Lynch JW
Cancer Causes Control; 2013 Jul; 24(7):1417-26. PubMed ID: 23649232
[TBL] [Abstract][Full Text] [Related]
35. [Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010].
Ponti A; Mano MP; Tomatis M; Baiocchi D; Barca A; Berti R; Bisanti L; Casella D; Deandrea S; Delrio D; Donati G; Falcini F; Frammartino B; Frigerio A; Mantellini P; Naldoni C; Orzalesi L; Pagano G; Pietribiasi F; Ravaioli A; Sedda ML; Taffurelli M; Cataliotti L; Segnan N
Epidemiol Prev; 2012; 36(6 Suppl 1):87-95. PubMed ID: 23293273
[TBL] [Abstract][Full Text] [Related]
36. Successful first round results of a Turkish breast cancer screening program with mammography in Bahcesehir, Istanbul.
Kayhan A; Gurdal SO; Ozaydin N; Cabioglu N; Ozturk E; Ozcinar B; Aribal E; Ozmen V
Asian Pac J Cancer Prev; 2014; 15(4):1693-7. PubMed ID: 24641392
[TBL] [Abstract][Full Text] [Related]
37. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.
de Roos MA; van der Vegt B; de Vries J; Wesseling J; de Bock GH
Ann Surg Oncol; 2007 Jul; 14(7):2097-104. PubMed ID: 17453296
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
39. [Proportion of breast cancer in women aged 50 to 69 years from Girona, Spain, according to detection method].
Puig-Vives M; Osca-Gelis G; Camprubí-Font C; Vilardell ML; Izquierdo A; Marcos-Gragera R
Med Clin (Barc); 2014 Oct; 143(7):300-2. PubMed ID: 24378145
[TBL] [Abstract][Full Text] [Related]
40. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
